Prosecution Insights
Last updated: October 04, 2026

Lile Method Research LLC

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Lile Method Research LLC has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and a matching number of distinct art units, showing a distributed examiner pool for its current filings. This distribution suggests that the company's intellectual property covers varied technical sub-fields within the broader biotechnology sector.

SEAMAN, D MARGARET M is identified as the busiest examiner, though they are responsible for only 1 pending office action. This distribution indicates that the workload is shared among the assigned staff. For the practitioner, this means that the prosecution of the pending office actions will proceed independently, with no single examiner's perspective dominating the portfolio's current trajectory. The presence of multiple art units for a small number of actions highlights a decentralized review process for this specific portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (50%)
Double-patenting + other1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SEAMAN, D MARGARET M 1 76.5% +8.0%
REYNOLDS, FRED H 1 33.0% +39.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18370919 COMPOSITIONS AND METHODS FOR INCREASING GLUTATHIONE LEVELS REYNOLDS, FRED H —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18370919 COMPOSITIONS AND METHODS FOR INCREASING GLUTATHIONE LEVELS REYNOLDS, FRED H —

Top Art Units

Art UnitApps
1625 1
1658 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18370931 COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING TUBERCULOSIS AND MRSA SEAMAN, D MARGARET M 1625 §103§112DP Non-Final OA — Pending Sep 21, 2023
18370919 COMPOSITIONS AND METHODS FOR INCREASING GLUTATHIONE LEVELS REYNOLDS, FRED H 1658 §101§103§112DP Final Rejection — Pending Sep 21, 2023

Managing Lile Method Research LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month